288. Autoimmune acquired coagulation factor deficiency Clinical trials / Disease details

Clinical trials : 205 / Drugs : 238 - (DrugBank : 31) / Drug target genes : 18 - Drug target pathways : 26

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01800435 (ClinicalTrials.gov)	October 2011	15/2/2013	A Comparison Study of Bypassing Agent Therapy With and Without Tranexamic Acid in Haemophilia A Patients With Inhibitor	Whole Blood Clot Stability and Thrombin Generating Capacity Following Treatment With Bypassing Agents (BPA) With and Without and Tranexamic Acid (TXA) in Haemophilia A Patients With inhibitor-an In-vivo Prospective Crossover Study	Hereditary Factor VIII Deficiency Disease With Inhibitor	Drug: aPCC, aPCC + TXA;Drug: rFVIIa , rFVIIa + TXA	Oslo University Hospital	NULL	Completed	18 Years	65 Years	Male	6	Phase 4	Norway
2	NCT00168077 (ClinicalTrials.gov)	September 2005	12/9/2005	Prothrombin Complex Concentrate for Anticoagulant Reversal	Efficacy and Tolerance of BERIPLEX® P/N in Subjects With Acquired Deficiency of Coagulation Factors II, VII, IX and X Due to Oral Anticoagulation	Acquired Coagulation Factor Deficiency	Drug: Prothrombin Complex Concentrate	CSL Behring	NULL	Completed	18 Years	N/A	Both	40	Phase 3	Austria;Germany;Hungary;Israel;Lithuania;Netherlands;Poland;Switzerland